Becton, Dickinson and Company

BDX · NYSE

Becton Dickinson reported FY2025 revenue of $21.84 billion and Q2 FY2026 revenue of $4.71 billion, with the official record tying the thesis to medtech scale, portfolio reshaping, hospital demand, margin recovery, debt and cash conversion.

Follow Add to Watchlist Ask Question

NYSE BDX Coverage Bootstrap Becton, Dickinson and Company

Latest ReportMay 19, 2026BD: the medtech reset has to turn hospital scale back into cleaner earningsView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.